Multiple Assemblies exist for SMTL entry 5mw3
Crystal structure of Dot1L in complex with inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6-(pent-2-yn-1-yl)quinoline-4,6-diamine] and inhibitor CPD2 [(R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine]; X-RAY DIFFRACTION 2.09 Å

	SMTL ID 5mw3.1 Ligands N~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine; (3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine; L(+)-TARTARIC ACID Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 5mw3.2 Ligands N~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine; (3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer